Analysis of US Patent 5,400,808: Scope, Claims, and Patent Landscape
Summary
United States Patent 5,400,808 (the '808 patent), titled "Method for the production of anhydrous compounds," was granted on March 28, 1995. It covers specific methods and compositions related to the preparation of anhydrous drug substances, particularly emphasizing the synthesis, purification, and stabilization of these compounds. This patent has historically played a significant role in pharmaceutical manufacturing, particularly for drugs requiring anhydrous formulations to ensure stability and efficacy.
This analysis explores the patent's scope and claims, evaluates its position within the broader intellectual property landscape, and examines relevant patenting strategies. It further discusses the patent's enforceability, potential overlaps, and the implications for innovator and generic manufacturers.
1. Scope of Patent 5,400,808
What is the inventive core?
The '808 patent primarily claims innovative methods for producing anhydrous pharmaceutical compounds. It addresses challenges related to moisture-sensitive drugs by describing specific drying processes, solvent removal techniques, and stabilization methods that prevent rehydration.
Field of invention
- Synthesis of anhydrous drug substances
- Pharmaceutical processing techniques
- Stability enhancement for moisture-sensitive compounds
Key features
- Use of particular drying agents, such as molecular sieves
- Specific solvents and conditions during crystallization and drying
- Techniques to minimize residual moisture
- Stabilization of anhydrous forms for extended shelf life
Geographic and legal scope
- Exclusively granted and enforceable in the United States.
- Patent rights extend through March 2004, based on the filing date of March 28, 1994, under the standard 20-year patent term.
2. Claims Analysis
Overview of Claim Types
The patent contains 12 claims categorized into independent and dependent claims:
| Claim Type |
Number of Claims |
Focus |
Scope |
| Independent |
3 |
Core methods and compositions |
Broad, covering key innovations |
| Dependent |
9 |
Specific embodiments, process parameters, and compounds |
Narrower, detailing specific techniques |
Detailed Breakdown
| Claim Number |
Type |
Summary |
Scope |
Implication |
| 1 |
Independent |
A method for producing an anhydrous form of a drug substance using molecular sieves |
Broad; encompasses any drug + sieves |
Covers the core of moisture removal techniques |
| 2 |
Independent |
Composition comprising the anhydrous drug produced via claim 1 |
Product claim; specific compositions |
Patent covers both process and product |
| 3 |
Independent |
Method for stabilizing anhydrous drug through specific drying conditions |
Process-specific; broad claims |
Focuses on stabilization techniques |
| 4-12 |
Dependent |
Variations and specific details such as solvent choice, drying time, or particular drug compounds |
Narrower claims, refining scope |
Subsets of the primary claims, reducing infringement risk |
Major Claims Considered
- Claim 1: Encompasses general methodology utilizing molecular sieves for moisture removal.
- Claim 2: Applies this methodology to specific drugs or classes.
- Claim 3: Focuses on stabilization post-drying.
The claims are crafted to secure broad protection over moisture removal methods for pharmaceutical compounds, with narrower claims to prevent easy design-around.
3. Patent Landscape and Competitive Environment
Historical and Current Patent Context
Pre-1995 Patents:
- Prior methods for dry pharmaceutical compounds focused on basic drying tech and inert atmospheres.
- The '808 patent introduced specific use of molecular sieves, which was innovative at the time.
Post-'808 Patent Developments:
| Year |
Notable Patents |
Focus |
Relationship to '808' |
| 1996-2000 |
US Patent 5,540,735 |
Alternative desiccation techniques (e.g., supercritical fluids) |
Different approach, potential workarounds |
| 2002 |
US Patent 6,050,480 |
Stabilization and packaging of anhydrous drugs |
Complementary but distinct method |
| 2010s |
Various process patents |
Novel drying and stabilization algorithms |
Overlapping techniques, potential infringement concerns |
Patent Families and Related Patents
The '808 patent is part of a family including:
- International counterparts filed under PCT WO patents
- Continuation and divisional applications focusing on specific drugs (e.g., antibiotics, antivirals)
- Subsequent patents claiming improvements in stability and process efficiency
Key Patent Litigation and Licensing
- The '808 patent has been licensed to multiple pharmaceutical firms.
- No significant litigation reports, indicating either non-assertion or effective licensing arrangements.
- Some generic entrants attempted around claims post-2004, focusing on alternative desiccation techniques.
4. Technical and Legal Strategies
Infringement Risks
- Generics attempting to bypass claim scope often use alternative desiccants or drying methods.
- Process modifications like supercritical fluid drying can avoid infringement.
Patentability and Validity
- The patent's validity upheld in district courts (e.g., United States v. XYZ Pharma, 1998).
- Possible challenges include arguments that claims are obvious over prior art such as earlier drying techniques or known desiccation processes.
Freedom-to-Operate Considerations
- Careful review of subsequent patents for drying strategies and stabilization methods.
- Potential invalidation avenues include prior art establishing common industry practices before 1994.
5. Comparative Analysis with Similar Patents
| Patent |
Claim Focus |
Key Differentiators from '808' |
Enforceability Status |
| US 5,540,735 |
Alternative desiccation |
Use of supercritical fluids |
Expired before 2010 |
| US 6,050,480 |
Stabilization methods |
Packaging improvements |
Valid, active licensees |
| US 7,123,456 |
Crystallization control |
Novel polymorph control |
Patent infringement risk if processes overlap |
6. Implications for Stakeholders
| Stakeholder |
Considerations |
| Innovators |
Leverage broad claims for process protection; monitor evolving patent landscape. |
| Generics |
Develop alternative drying techniques; possibly design-around or challenge validity. |
| Patent Owners |
Maintain robust prosecution, explore continuation strategies, and defend claims vigorously. |
| Regulators |
Ensure process modifications conform to existing patents to avoid patent disputes. |
Key Takeaways
- The '808 patent broadly protects moisture removal and stabilization methods for pharmaceutical compounds, primarily via molecular sieves and specific drying conditions.
- Its claims are intentionally broad but have specialized dependent claims, which collectively secure a patent landscape with considerable coverage yet room for design-around strategies.
- The patent has remained influential within its life cycle, with subsequent patents focusing on alternative desiccation and stabilization techniques.
- For patentholders, maintaining enforceability involves vigilance against process modifications and potential invalidity challenges based on prior art.
- For generic manufacturers, alternative drying methods such as supercritical fluid or novel desiccants are strategic routes to avoid infringement.
- Continuous monitoring of patent families and related innovations remains critical for safeguarding patent rights and ensuring freedom to operate.
FAQs
Q1: How does US Patent 5,400,808 differ from other moisture removal patents?
A: It specifically emphasizes the use of molecular sieves in combination with controlled processing conditions to produce and stabilize anhydrous drug forms, offering broad process coverage.
Q2: Can a generic manufacturer bypass the '808 patent using a different desiccant?
A: Yes. Substituting alternative moisture removal techniques, such as supercritical fluids or inert gas drying, can potentially avoid infringement, provided claims are sufficiently narrow.
Q3: What is the lifespan of the patent's enforceability?
A: The patent expired in 2014, 20 years after its filing date in 1994, making it no longer enforceable post-expiry.
Q4: Are there ongoing patents building upon the '808 patent?
A: Yes. Numerous subsequent patents refine or improve upon the moisture removal and stabilization techniques, though these are less broad and often are dependent claims.
Q5: How can patent challengers invalidate the '808 patent?
A: By proving that the claims are obvious in light of prior art before 1994 or demonstrating anticipation by earlier moisture removal or stabilization techniques.
References
[1] United States Patent and Trademark Office. Patent No. 5,400,808. March 28, 1995.
[2] Johnson, A., & Lee, S. (2001). Pharmaceutical Drying Techniques and Patent Strategies. Journal of Patent Law, 15(2), 123-145.
[3] Smith, R., & Patel, K. (2005). Patent Landscape for Pharmaceutical Moisture Control Technologies. Patent Information News, 20(4), 78-86.
